- 5
- 0
- 约1.96万字
- 约 17页
- 2017-05-03 发布于浙江
- 举报
Human immunodeficiency virus-associated nephropathy
PAGE \* MERGEFORMAT 17
Human immunodeficiency virus-associated nephropathy
In recent years, awareness of human immunodeficiency virus-associated nephropathy (human immunodeficiency virus-associated nephropathy, HIVAN) of treatment made some useful attempts. In these early studies, routine immunization is equally effective inhibitors of the HIVAN? Can promote the occurrence of HIV infection in the development? HIVAN whether to increase the risk of opportunistic infections in patients with combined? HIV infection in end-stage renal disease (ESRD) in patients with hemodialysis (HD ) in the treatment will result in HIV cross-infection between patients in hemodialysis? If cross-infection What are the possible ways? HIV can spread in renal transplant patients, anti-retroviral therapy in renal transplant patients is safe and a series of problems researchers and patient focus. This paper will present the following two aspects of the progress made in the treatment of HIVAN to do an overview of: ① in the early kidney disease to prevent progression to ESRD treatment carried out; ② against HIV infection in the treatment of patients with ESRD.
1 ESRD pre-treatment
1.1 Glucocorticoid preliminary clinical studies have shown that corticosteroids can improve renal function in adult patients with HIVAN, reduce urinary protein [1 ~ 4], reducing renal vascular disease and mitigate the tubulointerstitial inflammation [2], but the reduction of serum creatinine (SCr) concentration increased again [2] and for some children with HIVAN is invalid. Affect the efficacy of glucocorticoid main factors of HIV infection in synergy factor, infection stage and age of the patient. Glucocorticoid mechanism of action is not yet precise, and is now a clear and impact of interstitial immune cells in the [2], while glucocorticoids may also directly affect the glomerular filtration rate (GFR) and glomerular basement membrane permeability .
Glucocorticoid treatment HIVAN major complications of o
您可能关注的文档
- HR How to help businesses grow rapidly.doc
- HR growth is painful!.doc
- HSH injection infusion on acute intracranial hypertension associated with hemorrhagic shock in dogs brain tissue pathology and the impact of oxygen free radicals.doc
- Hsieh Fu-Liang Tan fruit and brand building strategy (one of the series).doc
- Hsieh Fu-Liang Tan fruit and brand building strategy (Series 2).doc
- HSG vagal reflex during observation and treatment.doc
- Hsieh Fu-Liang Tan a supermarket fruit- services should be 'three fruits'.doc
- Hsiao see where the market- - Button Q Medicines and Health Products Market in 2002.doc
- HSAFP for liver cancer and the efficacy of TACE prognostic value of surgery.doc
- Hsieh Fu-Liang Tan fruit and brand building strategy (Series 5).doc
- 2026年及未来5年内中国液体氩气行业投资前景及策略咨询研究报告.docx
- 2026年及未来5年内中国黄铜合页行业投资前景及策略咨询研究报告.docx
- 2026年及未来5年内中国竹工艺家具行业投资前景及策略咨询研究报告.docx
- 2025年中国微机数显自动分析仪市场调查研究报告.docx
- 2026年及未来5年内中国微尘白色粉笔行业投资前景及策略咨询研究报告.docx
- 2025年中国微电脑型压胶机市场调查研究报告.docx
- 2026年及未来5年内中国数字化等功游泳训练测试系统行业投资前景及策略咨询研究报告.docx
- 2025年中国圆形花瓶市场调查研究报告.docx
- 2026年及未来5年内中国植物纤维静淀过滤器行业投资前景及策略咨询研究报告.docx
- 2025年中国超音波手套机市场调查研究报告.docx
最近下载
- 四川省2025年中考数学真题试卷十五套附答案.pdf VIP
- 《数据库原理与应用》课程标准.pdf VIP
- 本科论文毕设-基于JAVA酒店管理系统毕业设计论文.doc VIP
- 2025年德州职业技术学院单招笔试数学试题库含答案解析.docx VIP
- 氟化物微纳复合玻璃与透明陶瓷:设计原理、制备工艺与性能研究.docx VIP
- 2025海上风电系统智能运维的数字孪生技术(英文).pdf VIP
- 2025年德州职业技术学院单招《数学》真题(重点)附答案详解.docx VIP
- 牵引供电变电所-分区所-AT所.pdf VIP
- 投标产品质量、供货、售后服务、残次品退换承诺方案.docx VIP
- 子宫肌瘤的诊治中国专家共识解读.docx VIP
原创力文档

文档评论(0)